Enriched pathways for major depressive disorder identified from a genome-wide association study
Open Access
- 16 January 2012
- journal article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 15 (10) , 1401-1411
Abstract
Major depressive disorder (MDD) has caused a substantial burden of disease worldwide with moderate heritability. Despite efforts through conducting nuKeywords
This publication has 46 references indexed in Scilit:
- Gene set analysis of genome-wide association studies: Methodological issues and perspectivesGenomics, 2011
- Common variants conferring risk of schizophrenia: A pathway analysis of GWAS dataSchizophrenia Research, 2010
- Poor replication of candidate genes for major depressive disorder using genome-wide association dataMolecular Psychiatry, 2010
- Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studiesMolecular Psychiatry, 2009
- Cranial sensory ganglia neurons require intrinsic N-cadherin function for guidance of afferent fibers to their final targetsNeuroscience, 2009
- Calcium signaling in immune cellsNature Immunology, 2008
- Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccoloMolecular Psychiatry, 2008
- Pathway analysis of seven common diseases assessed by genome-wide associationGenomics, 2008
- Combiningp‐values in large‐scale genomics experimentsPharmaceutical Statistics, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005